Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Cortene Inc. maintains a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action associated with this portfolio. This 1 action is assigned to 1 distinct examiner, BUCCINI, MICHELLE CALLAHAN, who operates within 1 distinct art unit. The busiest examiner, BUCCINI, MICHELLE CALLAHAN, is responsible for 1 pending action, which represents the entirety of the company's current pending workload. This concentration indicates a very specific focus for the active patent prosecution.
With only 1 pending office action and 1 distinct examiner, the company's immediate patenting strategy is centered on 1 point of contact at the patent office. The presence of 1 distinct art unit suggests that the current matter falls within a specific technical niche of Biotechnology & Pharmaceuticals. Practitioners can focus their efforts on the examination history and preferences of BUCCINI, MICHELLE CALLAHAN. Because the busiest examiner pending count of 1 matches the total number of pending office actions, the resolution of this case is the primary factor in the portfolio's current progress.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BUCCINI, MICHELLE CALLAHAN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18550798 | IMPROVED METHODS OF TREATING DISEASES RESULTING FROM A MALADAPTED STRESS RESPONSE | BUCCINI, MICHELLE CALLAHAN | — |
| Art Unit | Apps |
|---|---|
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18550798 | IMPROVED METHODS OF TREATING DISEASES RESULTING FROM A MALADAPTED STRESS RESPONSE | BUCCINI, MICHELLE CALLAHAN | 1675 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial